Showing results (1-10 of 588) with videos related to
Sort By:
Pageof 59
Expert Review of Anticancer Therapy|June 24, 2014
Maintenance therapy in epithelial ovarian cancer: from chemotherapy to targeted agentsCristina Falci, Maria Vittoria Dieci, Valentina Guarneri, et al.Recenti Progressi in Medicina|December 20, 2021
[Target therapy and governance: the breast cancer PDTA of the Venetian Oncology Network.]Pierfranco ConteThe Oncologist|October 2, 2004
Safety of intravenous and oral bisphosphonates and compliance with dosing regimensPierFranco Conte, Valentina GuarneriThe Breast Journal|January 12, 2007
Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspectivePierFranco Conte, Antonio FrassoldatiClinical Breast Cancer|May 22, 2012
The next generation of biologic agents: therapeutic role in relation to existing therapies in metastatic breast cancerPierFranco Conte, Valentina GuarneriThe Oncologist|July 18, 2009
Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapyValentina Guarneri, PierFranco ConteSeminars in Oncology|October 19, 2004
Bisphosphonates in the treatment of skeletal metastasesPierfranco Conte, Robert ColemanCancer Cell|April 13, 2016
Interfering with CCL5/CCR5 at the Tumor-Stroma InterfaceVincenzo Bronte, Emilio BriaCancer Immunology Research|August 8, 2025
Unlocking the Immune Response in ALK-Rearranged Lung AdenocarcinomaAntonio Vitale, Emilio BriaClinical Breast Cancer|February 14, 2008
Evolving nonendocrine therapeutic options for metastatic breast cancer: how adjuvant chemotherapy influences treatmentPierfranco Conte, Valentina Guarneri, Carmelo BengalaPageof 59